Medpace Holdings, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Medpace Holdings, Inc. (MEDP) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 158.03 million shares for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-10-31.
Discontinued › Income Statement
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2017-10-31
- Medpace Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-09-30 was 158.03M shares, a 155.32% increase year-over-year.
- Medpace Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-06-30 was 15.03M shares.
- Medpace Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-03-31 was 75.19M shares, a 71.51% decline year-over-year.
- Medpace Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2016-09-30 was 61.90M shares.
- Medpace Holdings, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2015 was 0.00 shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2017-09-30 | 158.03M shares 10-Q · filed 2017-10-31 | 90.55M shares 10-Q · filed 2017-10-31 | ||||
| 2017-06-30 | 15.03M shares 10-Q · filed 2017-08-01 | 46.12M shares 10-Q · filed 2017-08-01 | ||||
| 2017-03-31 | 75.19M shares 10-Q · filed 2017-05-02 | |||||
| 2016-09-30 | 61.90M shares 10-Q · filed 2017-10-31 | 62.00K shares 10-Q · filed 2016-11-03 | 25.70M shares 10-Q · filed 2017-10-31 | 26.00K shares 10-Q · filed 2016-11-03 | ||
| 2016-06-30 | 25.58M shares 10-Q · filed 2017-08-01 | |||||
| 2016-03-31 | 263.92M shares 10-Q · filed 2017-05-02 | |||||
| 2015-12-31 | 0.00 shares 10-K · filed 2017-02-28 | |||||
| 2015-09-30 | 0.00 shares 10-Q · filed 2016-11-03 | 0.00 shares 10-Q · filed 2016-11-03 | ||||
| 2014-12-31 | 0.00 shares 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |